Skip to Main Content

Advertisement

Skip Nav Destination

OnlineFirst

Review July 25 2023
Circulating Tumor DNA to Drive Treatment in Metastatic Colorectal Cancer
Clin Cancer Res (2023)
Research Article July 24 2023
The Clinical Implications of Reversions in Patients with Advanced Pancreatic Cancer and Pathogenic Variants in BRCA1, BRCA2, or PALB2 After Progression on Rucaparib
Clin Cancer Res CCR-23-1467.
Research Article July 20 2023
Cancer-associated fibroblast-like tumor cells remodel the Ewing sarcoma tumor microenvironment
Clin Cancer Res CCR-23-1111.
Translational Cancer Mechanisms and Therapy July 19 2023
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy July 19 2023
Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy July 18 2023
Dissecting the Mechanisms Underlying the Cytokine Release Syndrome (CRS) Mediated by T-Cell Bispecific Antibodies
Clin Cancer Res (2023)
Clinical Trials: Targeted Therapy July 14 2023
Safety and Efficacy of Tucatinib, Letrozole, and Palbociclib in Patients with Previously Treated HR+/HER2+ Breast Cancer
Clin Cancer Res (2023)
Clinical Trials: Immunotherapy July 14 2023
Safety, Efficacy, and Biomarker Analyses of Dostarlimab in Patients with Endometrial Cancer: Interim Results of the Phase I GARNET Study
Clin Cancer Res (2023)
Precision Medicine and Imaging July 13 2023
Associations between AI-Assisted Tumor Amphiregulin and Epiregulin IHC and Outcomes from Anti-EGFR Therapy in the Routine Management of Metastatic Colorectal Cancer
Clin Cancer Res (2023)
Research Article July 11 2023
Clinical and molecular features of long-term response to immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Clin Cancer Res CCR-23-1207.
Review June 30 2023
Facts and Hopes in Colorectal Cancer Immunotherapy
Clin Cancer Res (2023)
CCR Drug Updates June 29 2023
FDA Approval Summary: Tucatinib with Trastuzumab for Advanced Unresectable or Metastatic, Chemotherapy Refractory, HER2-Positive RAS Wild-Type Colorectal Cancer
Clin Cancer Res (2023)
CCR Drug Updates June 27 2023
FDA Approval Summary: Futibatinib for Unresectable Advanced or Metastatic, Chemotherapy Refractory Intrahepatic Cholangiocarcinoma with FGFR2 Fusions or Other Rearrangements
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy June 22 2023
Autocrine 17-β-Estradiol/Estrogen Receptor-α Loop Determines the Response to Immune Checkpoint Inhibitors in Non–Small Cell Lung Cancer
Clin Cancer Res (2023)
Precision Medicine and Imaging June 16 2023
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers
Clin Cancer Res (2023)
Review June 13 2023
Facts and Hopes: Immunocytokines for Cancer Immunotherapy
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy June 7 2023
Patient-Specific Targeting of the T-Cell Receptor Variable Region as a Therapeutic Strategy in Clonal T-Cell Diseases
Clin Cancer Res (2023)
CCR Drug Updates June 7 2023
FDA Approval Summary: Mirvetuximab Soravtansine-Gynx for FRα-Positive, Platinum-Resistant Ovarian Cancer
Clin Cancer Res (2023)
Clinical Trials: Immunotherapy June 2 2023
Efficacy of Nivolumab in Pediatric Cancers with High Mutation Burden and Mismatch Repair Deficiency
Clin Cancer Res (2023)
Translational Cancer Mechanisms and Therapy May 12 2023
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma
Clin Cancer Res (2023)
Biology of Human Tumors July 25 2016
GRM1 is An Androgen-Regulated Gene and its Expression Correlates with Prostate Cancer Progression in Pre-Clinical Models
Clin Cancer Res clincanres.0137.2016.
Page 3 of 3
Close Modal

or Create an Account

Close Modal
Close Modal